metabolic syndrome is associated with higher wall motion score and larger infarct size after acute myocardial infarction

conclusions we showed that patients with metabolic syndrome have larger infarct size compared to control subjects. background infarct size is an important surrogate end point for early and late mortality after acute myocardial infarction. despite the high prevalence of metabolic syndrome in patients with atherosclerotic diseases, adequate data are still lacking regarding the extent of myocardial necrosis after acute myocardial infarction in these patients. objectives in the present study we aimed to compare myocardial infarction size in patients with metabolic syndrome to those without metabolic syndrome using peak ck-mb and cardiac troponin i (ctni) at 72 hours after the onset of symptoms. patients and methods one-hundred patients with metabolic syndrome (group i) and 100 control subjects without metabolic syndrome (group ii) who experienced acute myocardial infarction were included in the study. diagnosis of metabolic syndrome was based on the national cholesterol education program adult treatment panel iii (ncep atp iii) guidelines published in 2001. myocardial infarction size was compared between the two groups of patients using peak ck-mb and ctni level in 72 hours after the onset of symptoms. results peak ck-mb and ctni in 72 hours were found to be significantly higher in patients with metabolic syndrome compared with control subjects (both p < 0.001). patients with metabolic syndrome also had markedly higher wall motion abnormality at 72 hours after the onset of symptoms as assessed by echocardiographically-derived wall motion score index (wmsi) (p < 0.001). moreover, statistically significant relationships were found between wmsi and peak ck-mb and also ctni at 72 hours (spearman's rho = 0.56, p < 0.001 and spearman's rho = 0.5, p < 0.001; respectively). however, association between wmsi and left ventricular ejection fraction was insignificant (spearman's rho = -0.05, p = 0.46).